Acute leukemia: diagnosis, management, and potential for cure.
作者信息
Stewart K, Keating A
出版信息
Can Fam Physician. 1988 Nov;34:2463-7.
Abstract
Acute leukemia is an uncommon malignant disorder resulting from the clonal proliferation of hematopoietic precursors of the myeloid or lymphoid lineages. Of the two major subgroups, acute lymphoblastic leukemia is more common in children, while acute myelogenous leukemia predominates in adults. With modern chemotherapy 60%-70% of all children with acute lymphoblastic leukemia can be long-term survivors and are potentially cured. Although the prognosis in acute myelogenous leukemia is less favourable, recent therapy, including bone-marrow transplantation, offers possible cure in selected patient groups.
摘要
相似文献
1
Acute leukemia: diagnosis, management, and potential for cure.
Can Fam Physician. 1988 Nov;34:2463-7.
2
Childhood leukemias--current status and future perspective.
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1995 Sep-Oct;36(5):322-7.
3
Modern trends in bone marrow transplantation for acute myeloid and acute lymphoblastic leukemia.
Curr Opin Oncol. 1992 Apr;4(2):247-58. doi: 10.1097/00001622-199204000-00003.
4
Diagnosis and treatment of childhood acute myelogenous leukemia.
Pediatr Clin North Am. 1997 Aug;44(4):847-62. doi: 10.1016/s0031-3955(05)70533-2.
5
[Allogenic transplantation of hematopoietic stem cells in the treatment of children with high-risk acute leukemia].
Cas Lek Cesk. 1998 Jun 15;137(12):363-7.
6
Treatment of acute leukemia in adults.
Curr Opin Oncol. 1992 Feb;4(1):53-65. doi: 10.1097/00001622-199202000-00008.
7
Higher cure rates in acute leukemia: now more probable with increasingly effective induction therapy.
Int J Clin Lab Res. 1992;21(4):273-7. doi: 10.1007/BF02591660.
8
Definition of acute biphenotypic leukemia.
Haematologica. 1997 Jan-Feb;82(1):64-6.
9
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
N Engl J Med. 1999 Jul 1;341(1):14-21. doi: 10.1056/NEJM199907013410103.
10
Leptin receptor in childhood acute leukemias.
Adv Exp Med Biol. 2013;756:155-61. doi: 10.1007/978-94-007-4549-0_20.
本文引用的文献
1
High-resolution chromosomes as an independent prognostic indicator in adult acute nonlymphocytic leukemia.
N Engl J Med. 1984 Sep 27;311(13):812-8. doi: 10.1056/NEJM198409273111302.
2
The increasing incidence of central nervous system leukemia in children. (Children's Cancer Study Group A).
Cancer. 1970 Aug;26(2):404-9. doi: 10.1002/1097-0142(197008)26:2<404::aid-cncr2820260222>3.0.co;2-i.
3
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.
Semin Oncol. 1987 Jun;14(2 Suppl 1):12-7.
4
Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies.
Semin Hematol. 1987 Jan;24(1):55-67.
5
Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide.
N Engl J Med. 1986 Jul 17;315(3):141-7. doi: 10.1056/NEJM198607173150301.
6
Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group.
J Clin Oncol. 1986 May;4(5):744-52. doi: 10.1200/JCO.1986.4.5.744.
7
Improved results of treatment of adult acute lymphoblastic leukemia.
Blood. 1987 Apr;69(4):1242-8.
8
Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia.
Blood. 1986 Feb;67(2):415-20.
9
Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia.
N Engl J Med. 1987 Aug 20;317(8):461-7. doi: 10.1056/NEJM198708203170801.
Zotero 插件